Skip to content
OpenCapital
Get started

Treace Medical Concepts, Inc. TMCI Net interest and investment income (loss)

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%
P/S1.3×-0.4×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s net interest and investment income (loss).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s net interest and investment income (loss)?
Treace Medical Concepts, Inc. (TMCI) reported net interest and investment income (loss) of $501K in Q1 2026.
How has Treace Medical Concepts, Inc.'s net interest and investment income (loss) changed year-over-year?
Treace Medical Concepts, Inc.'s net interest and investment income (loss) decreased by 40.4% year-over-year, from $841K to $501K.
What is the long-term trend for Treace Medical Concepts, Inc.'s net interest and investment income (loss)?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s net interest and investment income (loss) has grown at a 268.9% compound annual growth rate (CAGR), from $15K to $2.78M.